Screener
Core Laboratories CLB Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Core Laboratories in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Core Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 6:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-198109
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Operating lease liabilities | 12,097 | 11,456 |
| Income taxes payable | 4,214 | 4,255 |
| Other current liabilities | 17,373 | 16,680 |
| TOTAL CURRENT LIABILITIES | 104,734 | 106,015 |
| LONG-TERM DEBT, net | 114,460 | 110,255 |
| LONG-TERM OPERATING LEASE LIABILITIES | 41,285 | 42,309 |
| DEFERRED COMPENSATION | 28,165 | 29,381 |
| DEFERRED TAX LIABILITIES, net | 8,073 | 7,995 |
Item 1. Financial Statements
FAQ
- What is Core Laboratories's total current liabilities?
- Core Laboratories (CLB) reported total current liabilities of $104.73M in Q1 2026.
- How has Core Laboratories's total current liabilities changed year-over-year?
- Core Laboratories's total current liabilities increased by 1.0% year-over-year, from $103.73M to $104.73M.
- What is the long-term trend for Core Laboratories's total current liabilities?
- Over 3 years (2022 to 2025), Core Laboratories's total current liabilities has grown at a 0.9% compound annual growth rate (CAGR), from $103.14M to $106.02M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Core Laboratories's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude